Chemo- and bio-informatics insight into anti-cholinesterase potentials of berries and leaves of Myrtus communis L., Myrtaceae: an in vitro/in silico study.
Acetylcholinesterase
Beta-bourbonene
Insecticides
Myrtle
Phyto-nootropics
Sesquiterpenes
Terpenes
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
21 Nov 2023
21 Nov 2023
Historique:
received:
18
04
2022
accepted:
30
10
2023
medline:
23
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
epublish
Résumé
Myrtus communis L. (MC) has been used in Mesopotamian medicine. Here, the cholinesterase (ChE) inhibitory potential of its methyl alcohol extracts has been investigated and computationally dissected. The ChE inhibition has been measured based on usual Ellman's colorimetric method compared to a canonical ChE inhibitor, eserine. Through a deep text mining, the structures of phytocompounds (= ligands) of MC were curated from ChemSpider, PubChem, and ZINC databases and docked into protein targets, AChE (PDB 1EVE) and BChE (PDB 1P0I) after initial in silico preparedness and binding affinity (BA; kcal/mol) reported as an endpoint. The calculation of ADMET (absorption, distribution, metabolism, excretion, and toxicity) features of phytocompounds were retrieved from SwissADME ( http://www.swissadme.ch/ ) and admetSAR software to predict the drug-likeness or lead-likeness fitness. The Toxtree v2.5.1, software platforms ( http://toxtree.sourceforge.net/ ) have been used to predict the class of toxicity of phytocompounds. The STITCH platform ( http://stitch.embl.de ) has been employed to predict ChE-chemicals interactions. The possible inhibitory activities of AChE of extracts of leaves and berries were 37.33 and 70.00%, respectively as compared to that of eserine while inhibitory BChE activities of extracts of leaves and berries of MC were 19.00 and 50.67%, respectively as compared to that of eserine. Phytochemicals of MC had BA towards AChE ranging from -7.1 (carvacrol) to -9.9 (ellagic acid) kcal/mol. In this regard, alpha-bulnesene, (Z)-gamma-Bisabolene, and beta-bourbonene were top-listed low toxic binders of AChE, and (Z)-gamma-bisabolene was a more specific AChE binder. Alpha-cadinol, estragole, humulene epoxide II, (a)esculin, ellagic acid, patuletin, juniper camphor, linalyl anthranilate, and spathulenol were high class (Class III) toxic substances which among others, patuletin and alpha-cadinol were more specific AChE binders. Among intermediate class (Class II) toxic substances, beta-chamigrene was a more specific AChE binder while semimyrtucommulone and myrtucommulone A were more specific BChE binders. In sum, the AChE binders derived from MC were categorized mostly as antiinsectants (e.g., patuletin and alpha-cardinal) due to their predicted toxic classes. It seems that structural amendment and stereoselective synthesis like adding sulphonate or sulphamate groups to these phytocompounds may make them more suitable candidates for considering in preclinical investigations of Alzheimer's disease.
Sections du résumé
BACKGROUND
BACKGROUND
Myrtus communis L. (MC) has been used in Mesopotamian medicine. Here, the cholinesterase (ChE) inhibitory potential of its methyl alcohol extracts has been investigated and computationally dissected.
METHOD
METHODS
The ChE inhibition has been measured based on usual Ellman's colorimetric method compared to a canonical ChE inhibitor, eserine. Through a deep text mining, the structures of phytocompounds (= ligands) of MC were curated from ChemSpider, PubChem, and ZINC databases and docked into protein targets, AChE (PDB 1EVE) and BChE (PDB 1P0I) after initial in silico preparedness and binding affinity (BA; kcal/mol) reported as an endpoint. The calculation of ADMET (absorption, distribution, metabolism, excretion, and toxicity) features of phytocompounds were retrieved from SwissADME ( http://www.swissadme.ch/ ) and admetSAR software to predict the drug-likeness or lead-likeness fitness. The Toxtree v2.5.1, software platforms ( http://toxtree.sourceforge.net/ ) have been used to predict the class of toxicity of phytocompounds. The STITCH platform ( http://stitch.embl.de ) has been employed to predict ChE-chemicals interactions.
RESULTS
RESULTS
The possible inhibitory activities of AChE of extracts of leaves and berries were 37.33 and 70.00%, respectively as compared to that of eserine while inhibitory BChE activities of extracts of leaves and berries of MC were 19.00 and 50.67%, respectively as compared to that of eserine. Phytochemicals of MC had BA towards AChE ranging from -7.1 (carvacrol) to -9.9 (ellagic acid) kcal/mol. In this regard, alpha-bulnesene, (Z)-gamma-Bisabolene, and beta-bourbonene were top-listed low toxic binders of AChE, and (Z)-gamma-bisabolene was a more specific AChE binder. Alpha-cadinol, estragole, humulene epoxide II, (a)esculin, ellagic acid, patuletin, juniper camphor, linalyl anthranilate, and spathulenol were high class (Class III) toxic substances which among others, patuletin and alpha-cadinol were more specific AChE binders. Among intermediate class (Class II) toxic substances, beta-chamigrene was a more specific AChE binder while semimyrtucommulone and myrtucommulone A were more specific BChE binders.
CONCLUSION
CONCLUSIONS
In sum, the AChE binders derived from MC were categorized mostly as antiinsectants (e.g., patuletin and alpha-cardinal) due to their predicted toxic classes. It seems that structural amendment and stereoselective synthesis like adding sulphonate or sulphamate groups to these phytocompounds may make them more suitable candidates for considering in preclinical investigations of Alzheimer's disease.
Identifiants
pubmed: 37990185
doi: 10.1186/s12906-023-04241-z
pii: 10.1186/s12906-023-04241-z
pmc: PMC10664585
doi:
Substances chimiques
Cholinesterase Inhibitors
0
gamma-bisabolene
0
cadinol
0
Physostigmine
9U1VM840SP
Ellagic Acid
19YRN3ZS9P
Cholinesterases
EC 3.1.1.8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
421Subventions
Organisme : Razi University
ID : 8882
Informations de copyright
© 2023. The Author(s).
Références
Proteins. 2005 Apr 1;59(1):104-17
pubmed: 15696543
Int J Mol Sci. 2013 Mar 11;14(3):5608-32
pubmed: 23478436
Phytother Res. 2007 Mar;21(3):259-61
pubmed: 17186491
Neurosci Lett. 2005 Mar 16;376(3):210-4
pubmed: 15721223
J Neuropathol Exp Neurol. 2001 Jul;60(7):686-95
pubmed: 11444797
Z Naturforsch C J Biosci. 2016 Nov 1;71(11-12):393-402
pubmed: 27508961
Biochemistry. 1993 Jan 12;32(1):12-7
pubmed: 8418833
Int J Mol Sci. 2021 Jul 08;22(14):
pubmed: 34298986
Protein Sci. 2003 Dec;12(12):2675-84
pubmed: 14627729
Int J Food Sci Nutr. 2012 Jun;63(4):387-92
pubmed: 22022834
AMB Express. 2021 Jul 21;11(1):108
pubmed: 34287737
J Chem Inf Model. 2012 Nov 26;52(11):3099-105
pubmed: 23092397
J Enzyme Inhib Med Chem. 2010 Oct;25(5):622-8
pubmed: 20429778
Methods Mol Biol. 2015;1263:243-50
pubmed: 25618350
Biochemistry. 1992 Oct 13;31(40):9760-7
pubmed: 1356436
Chem Biodivers. 2021 Sep;18(9):e2100320
pubmed: 34245651
Phytother Res. 2014 Aug;28(8):1125-36
pubmed: 24497171
Nat Prod Rep. 2006 Apr;23(2):181-99
pubmed: 16572227
Annu Rev Pharmacol Toxicol. 1994;34:281-320
pubmed: 8042853
Sci Rep. 2021 Jul 6;11(1):13953
pubmed: 34230570
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907
pubmed: 12037327
Nat Prod Res. 2021 Jun;35(11):1887-1892
pubmed: 31293176
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Front Pharmacol. 2017 Jun 07;8:327
pubmed: 28638340
J Dent (Shiraz). 2019 Sep;20(3):195-202
pubmed: 31579695
Int Immunopharmacol. 2016 Jul;36:232-240
pubmed: 27177082
Mol Med Rep. 2018 May;17(5):7395-7402
pubmed: 29568860
Bioorg Med Chem. 2017 Feb 15;25(4):1352-1363
pubmed: 28089589
J Biol Chem. 1998 Jul 31;273(31):19509-17
pubmed: 9677373
In Silico Pharmacol. 2021 Jan 21;9(1):13
pubmed: 33520592
Mol Pharmacol. 1994 Feb;45(2):335-40
pubmed: 8114681
Sci Rep. 2020 Dec 10;10(1):21695
pubmed: 33303801
J Med Chem. 2006 Jun 1;49(11):3315-21
pubmed: 16722650